Philips announced it is recalling certain models of its respiratory machines, and this was announced early this week. The U.S. Food and Drug Administration also posted a notice about said product and cited possible contamination of plastic components as the reason for the recall.
According to Reuters, if the said plastic component is inside the respiratory machine's motor of the BiPAP or the bi-level positive airway pressure, the device may discharge certain chemicals that may be harmful to the users. The FDA said that such substances are called volatile organic compounds, and this is a concern.
Philips already recalled certain respiratory devices not long ago, and on Monday this week, it expanded the recall to some other respiratory machines. The company said about 1,700 devices are now covered in the latest recall.
The Dutch firm based in Amsterdam, Netherlands, confirmed that its subsidiary, Philips Respironics, is the one involved in the issue. Its spokesperson said that while a recall has been issued, they have not received any reports of injuries to patients related to the recall.
The firm's spokesperson said the call back on the devices was only put in place as a precautionary measure to prevent future occurrences. Of the 1,700 machines that are being recalled, 386 of them are in the United States and none in the Netherlands, where the brand is based.
"All affected devices with the non-conforming plastic will therefore be remediated in the June 2021 field action," the company stated via the US Food and Drug Administration's website. "The Philips Respironics BiPAP machines included in this recall may contain a plastic contaminated with a non-compatible material."
The company further stated in the notice, "If that plastic is in the device motor, it may release certain chemicals of concern called volatile organic compounds (VOCs). The plastic may also cause the machine to fail and stop working suddenly during use."
Finally, the FDA mentioned that some of the potential risks when the VOCs are inhaled by the patient include: headache, dizziness, irritation in the eyes, nose, respiratory tract (airway), and skin, hypersensitivity reaction, such as an allergic reaction or another immune system reaction, nausea or vomiting, and finally, toxic and cancer-causing effects.


Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
BOJ Expected to Deliver December Rate Hike as Economists See Borrowing Costs Rising Through 2025
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans
Oil Prices Rebound in Asia as Venezuela Sanctions Risks Offset Ukraine Peace Hopes
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal
Fed’s Dovish Tone Sends Dollar Lower as Markets Price In More Rate Cuts
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High
Gold Prices Hold Firm as Markets Await Fed Rate Cut; Silver Surges to Record High
Nvidia Develops New Location-Verification Technology for AI Chips
US Signals Openness to New Trade Deal as Brazil Shows Willingness, Says USTR Greer
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 



